This site is intended for Healthcare Professionals only.

Tag: Ipsen


Ipsen obtains development and commercial rights to mesdopetam

Ipsen and IRLAB have signed a licensing agreement, providing Ipsen exclusive worldwide development and commercial rights to mesdopetam, a novel dopamine D3-receptor antagonist. Mesdopetam is...

Steven Hildemann to take over as Ipsen’s chief medical officer

Ipsen on Tuesday announced Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance. The appointment...